KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other financing activities (2019 - 2025)

ClearPoint Neuro (CLPT) has disclosed Other financing activities for 5 consecutive years, with -$3.7 million as the latest value for Q4 2025.

  • Quarterly Other financing activities fell 210.95% to -$3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, down 73.13% year-over-year, with the annual reading at $1.9 million for FY2025, 73.13% down from the prior year.
  • Other financing activities hit -$3.7 million in Q4 2025 for ClearPoint Neuro, down from $2.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.4 million in Q4 2024 to a low of -$3.7 million in Q4 2025.
  • Historically, Other financing activities has averaged $901454.5 across 3 years, with a median of $1.3 million in 2025.
  • Biggest YoY gain for Other financing activities was 1672.66% in 2025; the steepest drop was 210.95% in 2025.
  • Year by year, Other financing activities stood at $586000.0 in 2021, then soared by 475.26% to $3.4 million in 2024, then crashed by 210.95% to -$3.7 million in 2025.
  • Business Quant data shows Other financing activities for CLPT at -$3.7 million in Q4 2025, $2.0 million in Q3 2025, and $2.3 million in Q2 2025.